Review of the Use of the Glutamate Antagonist Riluzole in Psychiatric Disorders and a Description of Recent Use in Childhood Obsessive-Compulsive Disorder

Central Administration of Minocycline and Riluzole Prevents Morphine-Induced Tolerance in Rats

(2009) Bohlool Habibi-Asl et al.   ANESTHESIA AND ANALGESIA

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial

(2009) Sanjay J. Mathew et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Interactions between riluzole and ABCG2/BCRP transporter

(2009) Aline Milane et al.   NEUROSCIENCE LETTERS

Riluzole in the Treatment of Mood and Anxiety Disorders

(2008) Christopher Pittenger et al.   CNS DRUGS

Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder

(2008) Christopher Pittenger et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole

(2008) M Banasr et al.   MOLECULAR PSYCHIATRY

Pharmacokinetics of riluzole: evidence for glucuronidation as a major metabolic pathway not associated with UGT1A1 genotype

(2007) H. J. M. van Kan et al.   BIOPHARMACEUTICS & DRUG DISPOSITION

Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1

(2007) Elena Fumagalli et al.   EUROPEAN JOURNAL OF PHARMACOLOGY